Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCQ PrEP for COVID-19 in HCWs
NCT04354870Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Apr 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in coronavirus disease 2019 (COVID-19), sponsored by NYU Langone Health. Started Apr 2020; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04354870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04354870.